Health economics simulation model

About

The MS Research Flagship has developed a health economics simulation model to assess the impact of MS treatments. Drug therapies, lifestyle interventions, public health programs, medical devices and/or surgical interventions can all be evaluated using the model.

The model can be used for multiple purposes to estimate the impact of interventions on clinical and cost outcomes of MS, as well as a range of economic analyses (cost-effectiveness, cost-utility or cost of disease). It can also be used to identify potential high risk patient profiles.

The economic model is available to clinicians, researchers and policy makers to ensure optimal disease course management of MS and the most efficient use of limited health care resources.

Outputs

The outputs from the model may include:

Life expectancy
Quality-adjusted life years
Direct costs
Indirect costs (productivity losses)
Probabilistic sensitivity analysis, including scatter plots and cost-effectiveness acceptability curves
Survival curves
Incremental cost-effectiveness ratios

How to collaborate

The model is run on a server housed at Menzies Institute for Medical Research, University of Tasmania (UTAS). An online user interface, powered by TreeAge Decision Analysis software, provides access to an independent, gold standard, validated, user friendly, transparent, decision analysis model. You do not need TreeAge software to run the model.

To access the model, applicants need to: